Health Technology Assessment (HTA) is an important tool in the healthcare decision making process. With ageing populations and an increasing burden due to chronic diseases, it is inevitable that Member States face some difficult decisions about the extent of expenditure for healthcare and how healthcare is composed. In its recommendations, HFE stressed the need to a more inclusive and transparent process, e.g. increasing stakeholder involvement as well as reporting by HTA authorities to a central online repository so that a real-time map of approved medical products are available to all EU citizens.
Link to download the recommendations below.